No Data
No Data
No Data
No Data
No Data
Inozyme Pharma Reports Increased Loss Amid Strategic Focus
TipRanksJun 9 23:51 ET
Inozyme Pharma Approves Executive Bonuses Amid Merger
TipRanksJun 2 07:58 ET
Jefferies Maintains Inozyme Pharma(INZY.US) With Hold Rating, Maintains Target Price $4
Moomoo NewsMay 19 15:31 ET · Ratings
Wells Fargo Maintains Inozyme Pharma(INZY.US) With Hold Rating, Maintains Target Price $4
Moomoo NewsMay 19 15:31 ET · Ratings
Piper Sandler Initiates Inozyme Pharma(INZY.US) With Hold Rating, Announces Target Price $4
Moomoo NewsMay 19 15:31 ET · Ratings
Needham Downgrades Inozyme Pharma to Hold From Buy
MT NewswiresMay 19 07:30 ET
Triple Nickle 1 : patience always pays
KingNY-Life : It's not going to rise anymore.
FattyChick
OP KingNY-Life
:
Is okay, im up 300-400%
- No more -